Olivier Fuseri, Sales Manager at Avicenna.AI, commented "We are thrilled that our solutions for Stroke are integrated in such a ground-breaking platform as deepcOS. Together we are committed to transform the future of radiology through our combined technologies.
The Munich-based MedTech Company deepc offers the leading Radiology AI platform deepcOS. Physicians and technologists can easily access an ecosystem of regulatory-cleared and globally leading AI solutions. AI-augmentation leads to higher detection rates of findings and streamlined workflows - providing radiologists with a safety net in their everyday routine, enabling them to process a higher number of scans. deepcOS offers streamlined setup & installation, contracting & billing, service & support while complying with all data protection & cybersecurity requirements.
Founded in 2018, Avicenna.AI develops medical imaging AI solutions for highly prevalent pathologies. The company uses artificial intelligence and deep learning to optimize many of a radiologist's manual tasks. Its CINA products leverage deep learning algorithms to identify acute abnormalities and support emergency room triage. Avicenna.AI.AI is co-founded by Cyril Di Grandi, who previously co-founded and successfully sold Olea Medical, and Dr. Peter Chang, a radiologist and internationally recognized expert in AI and deep learning
Back to HCB News